Literature DB >> 18476093

Potential fiscal consequences of universal screening for group-B streptococci.

G R Monif.   

Abstract

Year:  1996        PMID： 18476093      PMCID： PMC2364496          DOI： 10.1155/S1064744996000397

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN： 1064-7449


× No keyword cloud information.
  7 in total

1.  American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis.

Authors: 
Journal:  Pediatrics       Date:  1992-11       Impact factor: 7.124

2.  An obstetric approach to the prevention of early-onset group B beta-hemolytic streptococcal sepsis.

Authors:  H Minkoff; P Mead
Journal:  Am J Obstet Gynecol       Date:  1986-05       Impact factor: 8.661

3.  Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization.

Authors:  D M Strickland; E R Yeomans; G D Hankins
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

4.  Economic evaluation of maternal screening to prevent congenital syphilis.

Authors:  B Stray-Pedersen
Journal:  Sex Transm Dis       Date:  1983 Oct-Dec       Impact factor: 2.830

5.  Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Authors:  K M Boyer; S P Gotoff
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

6.  Neonatal group B streptococcal sepsis during 2 years of a universal screening program.

Authors:  R S Gibbs; R S McDuffie; F McNabb; G E Fryer; T Miyoshi; G Merenstein
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

7.  An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection.

Authors:  M K Yancey; P Duff
Journal:  Obstet Gynecol       Date:  1994-03       Impact factor: 7.661
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.